HERPES ZOSTER IN RA PATIENT TREATED WITH METHOTREXATE

This article describes herpes zoster (HZ) manifestation in RA patient treated with Methotrexate (MTX). The possibility of effective continuation of MTX after the symptoms of HZ resolve is demonstrated. The possibility of a causal relationship between the use of the MT and the manifestation HZ infect...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. V. Muraviev (Author), G. I. Gridneva (Author)
Format: Book
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2022-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4cb2ebcfe7bf4dce96e3c183a60a34d7
042 |a dc 
100 1 0 |a Yu. V. Muraviev  |e author 
700 1 0 |a G. I. Gridneva  |e author 
245 0 0 |a HERPES ZOSTER IN RA PATIENT TREATED WITH METHOTREXATE 
260 |b Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,   |c 2022-05-01T00:00:00Z. 
500 |a 2312-7821 
500 |a 2619-1164 
520 |a This article describes herpes zoster (HZ) manifestation in RA patient treated with Methotrexate (MTX). The possibility of effective continuation of MTX after the symptoms of HZ resolve is demonstrated. The possibility of a causal relationship between the use of the MT and the manifestation HZ infection, and treatment options are discussed. 
546 |a RU 
690 |a артрит, опоясревматоидный ывающий герпес, метотрексат. 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Безопасность и риск фармакотерапии, Vol 0, Iss 1, Pp 27-30 (2022) 
787 0 |n https://www.risksafety.ru/jour/article/view/294 
787 0 |n https://doaj.org/toc/2312-7821 
787 0 |n https://doaj.org/toc/2619-1164 
856 4 1 |u https://doaj.org/article/4cb2ebcfe7bf4dce96e3c183a60a34d7  |z Connect to this object online.